Statistics for Pharmanutra S.p.A. (id:4951 PHN)
Valuation metrics
Market cap
528.50M
Enterprise value
548.09M
Trailing P/E (ttm)
32.01
Forward P/E
25.40
PEG ratio
25.40
Price/Sales (ttm)
4.91
Price/Book (mrq)
9.56
Enterprise Value/Revenue
5.09
Enterprise Value/EBITDA
20.44
Overview
Shares outstanding
9.61M
Float
4.27M
Shares short
% Held by insiders
3.00%
% Held by institutions
3.00%
Average volume (10 days)
3.26K
Average volume (90 days)
Price summary
52-Week low
44.85
52-Week high
63.50
52-Week change
-6.30%
Beta
3.00
50-Day moving average
55.39
200-Day moving average
52.83
Dividends and splits
Forward annual dividend rate
3.40
Forward annual dividend yield
5.00
Trailing annual dividend rate
0.00%
Trailing annual dividend yield
0.00
5-Year annual dividend yield
1.41
Payout ratio
3.00
Dividend date
Ex-dividend date
May 6, 2024
Last split factor
2:1
Last split date
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
13.47%
Operating margin
31.14%
Operational effectiveness
Return on assets
14.04%
Return on equity
28.01%
Income statement
Revenue (ttm)
11.16
Revenue per share (ttm)
11.16
Quarterly revenue growth (yoy)
1.41
Gross profit (ttm)
33.60M
EBITDA
30.97M
Net income to common (ttm)
14.50M
Diluted EPS (ttm)
1.69
Quarterly earnings growth (yoy)
141.30%
Balance sheet
Total cash (mrq)
21.81M
Total cash per share (mrq)
2.27
Total debt (mrq)
27.05M
Total Debt/Equity (mrq)
49.36
Current ratio (mrq)
210.60%
Book value per share (mrq)
5.66
Cash flow
Cash flow statement
19.74M
Levered free cash flow (LFCF)
14.48M